ZSTK vs. NVO

Last updated Aug 1, 2026

ZSTK (ZeroStack Corp.) and NVO (Novo Nordisk A/S) are both stocks. ZSTK operates in Asset Management (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, ZSTK returned -80.99%/yr vs 2.48%/yr for NVO. Their 0.10 correlation means their historical movements had little consistent relationship.

Performance

ZSTK vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZeroStack Corp. (ZSTK) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ZSTK achieves a -75.72% return, which is significantly lower than NVO's -4.23% return.

ZSTK

• 1D: -1.30%
• 1M: -54.63%
• 6M: -86.76%
• YTD: -75.72%
• 1Y: -92.36%
• 3Y*: -74.39%
• 5Y*: -80.99%
• 10Y*: —
• ALL TIME*: -78.17%

NVO

• 1D: -8.78%
• 1M: -6.64%
• 6M: -18.01%
• YTD: -4.23%
• 1Y: 2.25%
• 3Y*: -14.32%
• 5Y*: 2.48%
• 10Y*: 7.55%
• ALL TIME*: 14.37%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
NVO Novo Nordisk A/S	$504.41M	$480.49M	$577.88M
ZSTK ZeroStack Corp.	$30.91K	$67.40K	$61.75K

ZSTK vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ZSTK ZeroStack Corp.	-75.72%	-84.42%	-23.70%	-70.34%	-87.21%	-67.64%
NVO Novo Nordisk A/S	-4.23%	-39.22%	-15.93%	54.84%	22.66%	47.63%

Correlation

The correlation between ZSTK and NVO is 0.20, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.20
Correlation (3Y) Balances recent behavior with more history.	0.11
Correlation (5Y) Shows whether the relationship held over a longer period.	0.11
Correlation (All Time) Calculated using the full available price history since May 11, 2021	0.10

The correlation between ZSTK and NVO shifts across timeframes, from 0.10 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ZSTK : $1.59M NVO : $209.19B
EPS ZSTK : -$17.81 NVO : DKK 27.42
PS Ratio ZSTK : 0.38 NVO : 4.15
PB Ratio ZSTK : 1.10 NVO : 6.70
Total Revenue (TTM) ZSTK : $40.03M NVO : DKK 327.80B
Gross Profit (TTM) ZSTK : -$1.25M NVO : DKK 268.30B
EBITDA (TTM) ZSTK : -$33.62M NVO : DKK 181.54B

Return for Risk

ZSTK vs. NVO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ZSTK

ZSTK Risk / Return Rank: 8
ZSTK Sharpe Ratio Rank: 16
ZSTK Sortino Ratio Rank: 5
ZSTK Omega Ratio Rank: 6
ZSTK Calmar Ratio Rank: 3
ZSTK Martin Ratio Rank: 11

NVO

NVO Risk / Return Rank: 47
NVO Sharpe Ratio Rank: 48
NVO Sortino Ratio Rank: 45
NVO Omega Ratio Rank: 46
NVO Calmar Ratio Rank: 48
NVO Martin Ratio Rank: 48

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ZSTK vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZeroStack Corp. (ZSTK) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ZSTK	NVO	Difference
Sharpe ratio: Return per unit of total volatility	-0.63	0.10	-0.73
Sortino ratio: Return per unit of downside risk	-1.68	0.47	-2.14
Omega ratio: Gain probability vs. loss probability	0.81	1.06	-0.26
Calmar ratio: Return relative to maximum drawdown	-0.97	0.11	-1.08
Martin ratio: Return relative to average drawdown	-1.30	0.20	-1.49

ZSTK vs. NVO - Sharpe Ratio Comparison

The current ZSTK Sharpe Ratio is -0.63, which is lower than the NVO Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of ZSTK and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ZSTK vs. NVO - Drawdown Comparison

The maximum ZSTK drawdown since its inception was -99.99%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ZSTK and NVO.

Drawdown Indicators

	ZSTK	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-74.70%	-25.29%
Max Drawdown (1Y) Largest decline over 1 year	-95.97%	-43.67%	-52.30%
Max Drawdown (3Y) Largest decline over 3 years	-99.10%	-74.70%	-24.40%
Max Drawdown (5Y) Largest decline over 5 years	-99.99%	-74.70%	-25.29%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	-99.99%	-65.79%	-34.20%
Average Drawdown Average peak-to-trough decline	-92.65%	-17.93%	-74.72%
Ulcer Index Depth and duration of drawdowns from previous peaks	72.05%	23.97%	+48.08%

Volatility

ZSTK vs. NVO - Volatility Comparison

ZeroStack Corp. (ZSTK) has a higher volatility of 32.02% compared to Novo Nordisk A/S (NVO) at 12.28%. This indicates that ZSTK's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ZSTK	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.02%	12.28%	+19.74%
Volatility (6M) Calculated over the trailing 6-month period	89.72%	36.87%	+52.85%
Volatility (1Y) Calculated over the trailing 1-year period	147.84%	46.77%	+101.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	133.18%	38.76%	+94.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	136.70%	32.76%	+103.94%

Dividends

ZSTK vs. NVO - Dividend Comparison

ZSTK has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.83%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVO Novo Nordisk A/S	3.83%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%
ZSTK ZeroStack Corp.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both ZSTK and NVO in my portfolio?

ZSTK and NVO have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ZSTK or NVO?

ZSTK has higher volatility (32.02%) compared to NVO (12.28%). In terms of maximum drawdown, ZSTK dropped -99.99% vs NVO's -74.70%.

Which has better risk-adjusted returns?

NVO currently has the higher Sharpe Ratio (0.10 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.